Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/25/2025

Diabetes Eye Exam Guidelines

Initial Screening Timing

  • The American Diabetes Association recommends that all individuals with type 2 diabetes should have a dilated comprehensive eye examination by an ophthalmologist or optometrist immediately at the time of diagnosis, while those with type 1 diabetes should be examined within 5 years of diagnosis 1, 2, 3
  • For type 1 diabetes patients, the first eye exam should be within 5 years after diabetes onset, as retinopathy typically requires at least 5 years of hyperglycemia to develop 1, 2, 3
  • Generally, eye exams are not necessary before age 10 years for type 1 diabetes patients, though clinical judgment should guide decisions for individual patients, particularly considering prepubertal diabetes duration 4
  • For type 2 diabetes patients, an immediate dilated comprehensive eye examination at diagnosis is recommended because patients may have had years of undiagnosed diabetes and significant risk of prevalent retinopathy already exists 1, 2, 3
  • Women with preexisting type 1 or type 2 diabetes planning pregnancy require comprehensive eye examination before conception and in the first trimester, with close follow-up throughout pregnancy 1, 2, 3
  • Gestational diabetes does not require special retinal screening, as these individuals are not at increased risk for diabetic retinopathy 1, 2, 3
  • The risk of progression is substantial, with a 52.3% prevalence of any retinopathy and 6.1% prevalence of proliferative diabetic retinopathy in early pregnancy among those with preexisting diabetes 1

Follow-Up Examination Frequency

  • Annual dilated retinal examinations are recommended for both type 1 and type 2 diabetes patients by an ophthalmologist or optometrist experienced in diabetic retinopathy 1, 2, 4
  • Every 1-2 years may be considered if there is no evidence of retinopathy from one or more annual exams and glycemic indicators are within goal range 1, 2, 3
  • At least annual examinations are recommended if any level of diabetic retinopathy is present 1, 2, 3
  • More frequent than annual examinations are recommended if retinopathy is progressing or sight-threatening 1, 2, 3

Alternative Screening Modalities

  • Retinal photography with remote reading or FDA-approved artificial intelligence algorithms are appropriate screening strategies for diabetic retinopathy 1, 2, 3
  • These programs must provide pathways for timely referral for comprehensive eye examination when indicated 1, 2, 3

Critical Referral Triggers

  • Immediate ophthalmology referral is required for any level of diabetic macular edema 1, 4
  • Immediate ophthalmology referral is required for severe nonproliferative diabetic retinopathy (NPDR) 1, 4
  • Immediate ophthalmology referral is required for any proliferative diabetic retinopathy (PDR) 1, 4

Special Considerations with GLP-1 Receptor Agonists

  • Assess retinopathy status before intensifying glucose-lowering therapy with GLP-1 RAs, as these agents are associated with increased risk of rapidly worsening diabetic retinopathy in randomized trials 1, 2, 3
  • Rapid reductions in A1C can be associated with initial worsening of retinopathy 1, 2, 3

Systemic Risk Factor Management

  • Optimize glycemic control to reduce risk or slow progression of retinopathy 5
  • Optimize blood pressure control to reduce risk or slow progression of retinopathy 5